重组Anti-Villin抗体[EPR3490]
Anti-Villin antibody [EPR3490]
- RabMAb
- Recombinant
- 了解详情
5
(1 Review)
|
(7 Publications)
Rabbit Recombinant Monoclonal Villin antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 7 publications.
查看别名
VIL, VIL1, Villin-1
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Villin antibody [EPR3490] (AB109516)
Intracellular flow cytometric analysis of Villin in permeabilized HT-29 cells, using ab109515 at a dilution of 1/10 (red) or a rabbit IgG (negative) (green).
- WB
Unknown
Western blot - Anti-Villin antibody [EPR3490] (AB109516)
All lanes:
Western blot - Anti-Villin antibody [EPR3490] (ab109516) at 1/10000 dilution
Lane 1:
Human small intestine lysate at 10 µg
Lane 2:
HT-29 lysate at 10 µg
Lane 3:
Caco-2 lysate at 10 µg
Predicted band size: 93 kDa
Observed band size: 95 kDa
false
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (7)
Recent publications for all applications. Explore the full list and refine your search
EBioMedicine 104:105181 PubMed38838469
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biotechnology journal 19:e2300390 PubMed38375564
2024
Applications
Unspecified application
Species
Unspecified reactive species
Tissue engineering and regenerative medicine 19:403-415 PubMed35122584
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Methods & clinical development 17:49-57 PubMed31890740
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 8:16393 PubMed30401824
2018
Applications
Unspecified application
Species
Unspecified reactive species
Biochemical and biophysical research communications 472:631-6 PubMed26966071
2016
Applications
Flow Cyt
Species
Human
Scientific reports 5:16479 PubMed26559489
2015
Applications
Flow Cyt
Species
Human
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com